Clinical trial
Effect of Vitamin D Supplementation on the Efficacy of Ustekinumab in the Treatment of Crohn's Disease
NCT05867784 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Wenzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Vitamin D Supplementation on the Efficacy of Ustekinumab in the Treatment of Crohn's Disease
- Lead sponsor
- Second Affiliated Hospital of Wenzhou Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2021
- Completion date
- March 15, 2023
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clinical efficacy, crohn's disease, ustekinumab, vitamin d supplementation